Molecular Instruments and Visiopharm team up for AI-powered RNA-ISH evolution
In a significant leap for molecular pathology, Molecular Instruments and Visiopharm have announced an ambitious partnership, integrating artificial intelligence (AI) into RNA In Situ Hybridization (RNA-ISH) technology. This strategic collaboration is set to revolutionize how researchers and clinicians explore gene expression in tissue samples, blending cutting-edge AI with advanced RNA-ISH assays to deliver unprecedented precision […]